Lux Capital is raising a $350 million fund, Lux Ventures 4, as Fierce Biotech has already noted. From my standpoint, without confirmation from the firm, it’s entirely possible that war chest will be used to invest in digital health and biotech companies. It also invests in energy and technology companies. But here’s a look at some of the healthcare companies that have turned its investors heads.
Mobile health
Pager uses mobile technology to do house calls. Users download an app to arrange a time to meet. Its board-certified doctors can do diagnostic exams, prescribe medications, order and interpret lab tests and X-rays, depending on the state. The New York-based digital health company was set up by Philip Eytan, Gaspard de Dreuzy and Oscar Salazar.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
HIPAA compliance
Aptible automates HIPAA compliance for Web-based and mobile applications. It manages servers, security, backups, encryption, and organizational permissions and helps them demonstrate proof of compliance.
Big data
Kyruus uses big data to provide more targeted referrals for patients match up physicians with patients.
Health Benefit Consultants, Share Your Expert Insights in Our Survey
Share some of the trends you are seeing among your clients across healthcare, including chronic conditions, behavioral health, healthcare navigation, and more.
Digital tools for pathology
3Scan‘s technology enables researchers, like pathologists, to get an extreme close-up of the 3-D structure of tissues and organ structures.
Nanotechnology
Kala Pharmaceuticals, a Johns Hopkins spinout, uses nanotechnology as part of a drug delivery platform to penetrate mucus to treat ophthalmic diseases.
Immunotherapy and vaccines
Genocea Biosciences This was a company Lux founded in 2006. It’s currently developing a genital herpes vaccine to be used in patients already infected with the disease.
